Total Funding
62
42
Total FundingSeed raised
Growth Score 62 in past quarter
-8 pts
Heat Score 42 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
109927
A:head is a biotech company that provides a unique approach to drug development services.
- Josh Bagley: Chief Scientific Officer
- Oliver Szolar: CEOPast Role: Savira pharmaceuticals, CEO
About the Company
a:head provides a unique approach to drug development services. They develop new therapeutics for the treatment of brain disorders based on human cerebral organoids. Their drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini-brains from human stem cells in
vitro.